Lv61
3180 积分 2022-04-08 加入
How to Design Next-generation of Antibody-Drug Conjugates for Cancer Treatment: Lessons from Unsuccessful Clinical Trials
1小时前
已完结
Chemoenzymatic Site-Specific Lysine Modification of Nanobodies and Subsequent Bioconjugation via Potassium Acyltrifluoroborate (KAT) Ligations
1小时前
已完结
Site-selective modification of native proteins
1小时前
已完结
Chemoenzymatic Labeling, Detection and Profiling of Core Fucosylation in Live Cells
8天前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
13天前
已完结
In Silico-Driven THIOMAB Approach for Stable PROTAC Conjugates by Docking Payloads in Antibody Cavities
20天前
已完结
Review on: BRD4 inhibitors for anticancer research
2个月前
已完结
Modular Synthesis of Anti-HER2 Dual-Drug Antibody-Drug Conjugates Demonstrating Improved Toxicity
3个月前
已完结
An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio
3个月前
已完结
High-Throughput Experimentation Reveals Scope and Limitations of Selective Phosphine Reductants and Enables One-Pot mAb Reduction/Conjugation
3个月前
已完结
皖公网安备34019202002308
